6-((3-Methoxyphenyl)thio)-5-methyl-7-propyl-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine

ID: ALA4228228

PubChem CID: 145971179

Max Phase: Preclinical

Molecular Formula: C17H21N5OS

Molecular Weight: 343.46

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCn1c(Sc2cccc(OC)c2)c(C)c2c(N)nc(N)nc21

Standard InChI:  InChI=1S/C17H21N5OS/c1-4-8-22-15-13(14(18)20-17(19)21-15)10(2)16(22)24-12-7-5-6-11(9-12)23-3/h5-7,9H,4,8H2,1-3H3,(H4,18,19,20,21)

Standard InChI Key:  FJMFWPUOJWKBOY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
   22.7231  -10.7060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.7220  -11.5255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4300  -11.9345    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.4282  -10.2971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0139  -11.9336    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.4258   -9.4799    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.1368  -10.7024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1416  -11.5210    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9217  -11.7695    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.3990  -11.1043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9139  -10.4449    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1619   -9.6663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2162  -11.0995    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   26.6290  -11.8048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2220  -12.5136    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6341  -13.2184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4521  -13.2141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8564  -12.4990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4420  -11.7971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6735  -12.4913    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.0888  -13.1951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.1787  -12.5452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6354  -13.1556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8925  -13.9313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  8  2  0
  7  4  2  0
  4  1  1  0
  2  5  1  0
  4  6  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11  7  1  0
 11 12  1  0
 10 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
 18 20  1  0
 20 21  1  0
  9 22  1  0
 22 23  1  0
 23 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4228228

    ---

Associated Targets(Human)

DHFR Tclin Dihydrofolate reductase (3072 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

DHFR Dihydrofolate reductase (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 343.46Molecular Weight (Monoisotopic): 343.1467AlogP: 3.47#Rotatable Bonds: 5
Polar Surface Area: 91.98Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.92CX LogP: 3.87CX LogD: 3.25
Aromatic Rings: 3Heavy Atoms: 24QED Weighted: 0.74Np Likeness Score: -1.09

References

1. Shah K, Lin X, Queener SF, Cody V, Pace J, Gangjee A..  (2018)  Targeting species specific amino acid residues: Design, synthesis and biological evaluation of 6-substituted pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitors and potential anti-opportunistic infection agents.,  26  (9): [PMID:29691153] [10.1016/j.bmc.2018.04.032]

Source